Mark A. Kronenfeld Insider Trading $PCRX Pacira BioSciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark A. Kronenfeld.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark A. Kronenfeld. Mark A. Kronenfeld is Director in Pacira Pharmaceuticals, Inc. ($PCRX).
Mark A. Kronenfeld in Pacira BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark A. Kronenfeld: Director
Holdings: 16,737 shares
Current Value: $698,770
Latest Transaction: Jun 11 2021
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark A. Kronenfeld in Pacira BioSciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Option Exercise | A | 60.96 | 7,626 | 464,881 | 7,626 | |
| Jun 11 2021 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,066 | 0 | 16,737 | 15.7 K to 16.7 K (+6.80 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,260 | 0 | 15,671 | 14.4 K to 15.7 K (+8.74 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 4,134 | 0 | 14,411 | 10.3 K to 14.4 K (+40.23 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 4,134 | 0 | 14,411 | 10.3 K to 14.4 K (+40.23 %) |
| Mar 08 2019 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Buy | P | 39.14 | 1,000 | 39,140 | 10,277 | 9.3 K to 10.3 K (+10.78 %) |
| Mar 08 2019 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Buy | P | 38.72 | 700 | 27,104 | 9,277 | 8.6 K to 9.3 K (+8.16 %) |
| Aug 30 2018 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Buy | P | 44.61 | 1,000 | 44,611 | 8,577 | 7.6 K to 8.6 K (+13.20 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 782 | 0 | 7,577 | 6.8 K to 7.6 K (+11.51 %) |
| Nov 13 2017 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Buy | P | 41.60 | 1,000 | 41,603 | 6,795 | 5.8 K to 6.8 K (+17.26 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,357 | 0 | 5,795 | 4.4 K to 5.8 K (+30.58 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,488 | 0 | 4,438 | 3 K to 4.4 K (+50.44 %) |
| Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Sell | S | 46.95 | 900 | 42,255 | 2,950 | 3.9 K to 3 K (-23.38 %) |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
| Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 2,000 | 0 | 3,850 | 1.9 K to 3.9 K (+108.11 %) |
| Jun 05 2014 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 81.00 | 8,000 | 648,000 | 8,000 | |
| Sep 13 2013 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Buy | P | 37.01 | 1,000 | 37,010 | 1,000 | 0 to 1,000 |
| Jun 14 2013 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 29.20 | 15,000 | 438,000 | 15,000 |
Page: 1